Scl Science Inc. (246960) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Scl Science Inc. (246960:KRX), powered by AI.

Current Price
₩1,703
P/E Ratio
-15.1
Market Cap
59.5B
Sector
Healthcare
What is the Scl Science Inc. stock price forecast?

Scl Science Inc. is currently trading at ₩1,703. View real-time AI analysis on Alpha Lenz.

What is Scl Science Inc. insider trading activity?

View the latest insider trading data for Scl Science Inc. on Alpha Lenz.

What is Scl Science Inc.'s P/E ratio?

Scl Science Inc.'s P/E ratio is -15.1.

Scl Science Inc.

KRX · 246960
₩1,703-47(-2.69%)Market closedKRX regular session 09:00–15:30 KST
Ask about Scl Science Inc.'s future dividend policy...
Alpha Chat Insight

Scl Science Inc. trades at a P/E of -15.1 (undervalued) with modest ROE of -19.7%. 3Y revenue CAGR of 290.4% highlights clear growth momentum.

Ask for details

Company Overview

Scl Science Inc. operates as a company within the dynamic field of scientific equipment and technology solutions. Its primary function is to develop, manufacture, and distribute a broad spectrum of cutting-edge instruments and devices essential for scientific research and analysis. The company caters to industries such as biotechnology, pharmaceuticals, agriculture, and environmental research, offering products that support experimentation, testing, and innovation in these fields. Scl Science Inc. is noted for its commitment to precision and quality, ensuring that its tools meet the rigorous standards required by scientists and researchers. It provides instruments used in varying applications, from laboratory settings to field-testing scenarios. By equipping professionals with reliable and advanced technologies, the company plays a crucial role in advancing scientific progress and technological development. In the financial market, Scl Science Inc. represents an entity that contributes significantly to sectors that rely heavily on research and development. Its presence underscores the importance of technological support in fostering innovation and enhancing efficiency within scientific communities, making it a notable contributor to the broader industry landscape.

CEO이경률, 백세연 (각자대표)
SectorHealthcare
IndustryMedical Devices
Employees61

Company Statistics

FY 2025

Profile

₩59,529,832,250Market Cap
₩22,010,565,270Revenue
34.02MShares Out
61Employees

Margins

19.09%Gross
0.84%EBITDA
-15.44%Operating
-21.68%Pre-Tax
-18.72%Net

Valuation

-15.13P/E
2.43P/B
2.70EV/Sales
447.92EV/EBITDA
-12.83P/FCF

Growth (CAGR)

290.45%Rev 3Yr
105.80%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-7.92%ROA
-19.69%ROE
-5.10%ROIC

Financial Health

₩4,173,315,780Cash & Cash Equivalents
₩52,252,474,720Net Debt
240.13%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Scl Science Inc. (ticker: 246960) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 61 employees. Market cap is $59.5B.

The current price is ₩1,703 with a P/E ratio of -15.13x and P/B of 2.43x.

ROE is -19.69% and operating margin is -15.44%. Annual revenue is $22.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Scl Science Inc. (246960) Stock Forecast 2026 ₩1,703 — Price, Financials & Analyst Targets | Alpha Lenz